Medicine
Atorvastatin 40 mg tablet
Atorvastatin 40 mg tablet is a generic prescription medicine for oral use, made by 40 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 - 25° C (68 - 77° F).
Key facts
- Active ingredient (INN)
- Atorvastatin
- Brand
- Sold under the generic name
- Strength
- 40 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 500 tablets, 10 blister pack, 1000 tablets and 236 more
- Manufacturers
- Dr. Reddy's LaboratoriesIndiaZydus LifesciencesIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaCiplaIndiaBioconIndiaAccord HealthcareIndiaCadila PharmaceuticalsIndiaCamber PharmaceuticalsIndia40 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20 - 25° C (68 - 77° F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C10AA05 Atorvastatin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 December 2011
- Identifiers
- RxCUI 617312, 617311, 259255 +1DailyMed set ID c3b70f79-45a3-0869-e053-2a95a90a3cdb, 1cc2dd41-a465-45b6-a80a-67c41af29cf8, 536b5e0d-1bb9-4c9d-a588-460d7647308b +37NDC 72189-239, 50090-5208, 59651-608 +37Application ANDA204991, ANDA209288, ANDA217118 +19
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 40 labelers. The register lists 239 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 500 tablet in 1 bottle | 43598-101-05 | Dr. Reddy's LaboratoriesIndia | 1 April 2024 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 43598-101-78 | Dr. Reddy's LaboratoriesIndia | 1 April 2024 |
| 1000 tablet in 1 bottle | 43598-101-87 | Dr. Reddy's LaboratoriesIndia | 1 September 2026 |
| 90 tablet in 1 bottle | 43598-101-90 | Dr. Reddy's LaboratoriesIndia | 1 April 2024 |
| 500 tablet in 1 bottle | 43598-832-05 | Dr. Reddy's LaboratoriesIndia | 29 August 2022 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 43598-832-78 | Dr. Reddy's LaboratoriesIndia | 29 August 2022 |
| 90 tablet in 1 bottle | 43598-832-90 | Dr. Reddy's LaboratoriesIndia | 29 August 2022 |
| 500 tablet in 1 bottle | 55111-123-05 | Dr. Reddy's LaboratoriesIndia | 17 July 2012 |
| 1000 tablet in 1 bottle | 55111-123-10 | Dr. Reddy's LaboratoriesIndia | 17 July 2012 |
| 30 tablet in 1 bottle | 55111-123-30 | Dr. Reddy's LaboratoriesIndia | 17 July 2012 |
| 60 tablet in 1 bottle | 55111-123-60 | Dr. Reddy's LaboratoriesIndia | 17 July 2012 |
| 90 tablet in 1 bottle | 55111-123-90 | Dr. Reddy's LaboratoriesIndia | 17 July 2012 |
| 90 tablet, film coated in 1 bottle | 69097-899-05 | CiplaIndia | 4 August 2016 |
| 1000 tablet, film coated in 1 bottle | 69097-899-15 | CiplaIndia | 4 August 2016 |
| 90 tablet, film coated in 1 bottle | 69097-946-05 | CiplaIndia | 16 November 2017 |
| 1000 tablet, film coated in 1 bottle | 69097-946-15 | CiplaIndia | 16 November 2017 |
| 1000 tablet in 1 bottle | 70710-1772-0 | Zydus LifesciencesIndia | 12 June 2024 |
| 500 tablet in 1 bottle | 70710-1772-5 | Zydus LifesciencesIndia | 12 June 2024 |
| 90 tablet in 1 bottle | 70710-1772-9 | Zydus LifesciencesIndia | 12 June 2024 |
| 1000 tablet in 1 bottle | 70771-1877-0 | Zydus LifesciencesIndia | 12 June 2024 |
| 500 tablet in 1 bottle | 70771-1877-5 | Zydus LifesciencesIndia | 12 June 2024 |
| 90 tablet in 1 bottle | 70771-1877-9 | Zydus LifesciencesIndia | 12 June 2024 |
| 90 tablet, film coated in 1 bottle | 16729-046-15 | Accord HealthcareIndia | 13 July 2021 |
| 1000 tablet, film coated in 1 bottle | 16729-046-17 | Accord HealthcareIndia | 6 August 2018 |
| 500 tablet, film coated in 1 bottle | 67877-513-05 | Ascend LaboratoriesIndia | 23 December 2018 |
| 1000 tablet, film coated in 1 bottle | 67877-513-10 | Ascend LaboratoriesIndia | 23 December 2018 |
| 2000 tablet, film coated in 1 bottle | 67877-513-23 | Ascend LaboratoriesIndia | 23 December 2018 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 67877-513-38 | Ascend LaboratoriesIndia | 23 December 2018 |
| 90 tablet, film coated in 1 bottle | 67877-513-90 | Ascend LaboratoriesIndia | 23 December 2018 |
| 500 tablet, film coated in 1 bottle | 59651-608-05 | Aurobindo PharmaIndia | 13 February 2024 |
| 30 tablet, film coated in 1 bottle | 59651-608-30 | Aurobindo PharmaIndia | 13 February 2024 |
| 90 tablet, film coated in 1 bottle | 59651-608-90 | Aurobindo PharmaIndia | 13 February 2024 |
| 1000 tablet, film coated in 1 bottle | 59651-608-99 | Aurobindo PharmaIndia | 13 February 2024 |
| 90 tablet, film coated in 1 bottle | 70377-079-11 | BioconIndia | 1 March 2023 |
| 500 tablet, film coated in 1 bottle | 70377-079-12 | BioconIndia | 1 March 2023 |
| 1000 tablet, film coated in 1 bottle | 70377-079-13 | BioconIndia | 1 March 2023 |
| 90 tablet, coated in 1 bottle | 71209-092-04 | Cadila PharmaceuticalsIndia | 6 July 2018 |
| 500 tablet, coated in 1 bottle | 71209-092-10 | Cadila PharmaceuticalsIndia | 6 July 2018 |
| 500 tablet, film coated in 1 bottle | 31722-426-05 | Camber PharmaceuticalsIndia | 12 September 2023 |
| 1000 tablet, film coated in 1 bottle | 31722-426-10 | Camber PharmaceuticalsIndia | 25 April 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 17 December 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Atorvastatin 40 mg tablet.
Other strengths and forms of Atorvastatin
Clinical summary
Atorvastatin is an HMG-CoA reductase inhibitor indicated to reduce the risk of myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD. MedsAcross supplies Atorvastatin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AtorvastatinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lipitor prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Atorvastatin 40 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.